Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

Postmenopausal women with excess male hormones may have ovarian tumors, and surgery usually cures them.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Biochemical markers help diagnose ovarian tumors in postmenopausal women.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

Early diagnosis, genetic testing, and innovative treatments are crucial for managing complex medical conditions.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

Hyaluronic Acid Profhilo® reduces skin inflammation and nerve-related pain in atopic dermatitis.

Mesenchymal stem cells could help treat radiation-induced bladder damage but more research is needed to overcome current limitations.

New regenerative medicine-based therapies for hair loss look promising but need more clinical validation.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

Human hair follicle stem cells improve ovarian function in mice with damaged ovaries.

More guidance on evaluating health interventions can improve investment in population health.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

Thymosin β4 and VEGF are important for blood vessel formation in many organs.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

CD99 is highly present in certain skin cells and could help treat skin conditions.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

The gel is safe and effective for treating oral mucositis from chemotherapy and radiation.

The document concludes that mouse models are helpful but have limitations for skin wound healing research, and suggests using larger animals and genetically modified mice for better human application.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Stem cell therapy shows promise but needs better safety and quality standards.

New technologies like AI, robotics, and stem cells have made hair transplants more effective and natural-looking.